BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16503265)

  • 1. Sustained elevation of circulating vascular endothelial growth factor after percutaneous angioplasty for peripheral arterial diseases.
    Liu TJ; Lai HC; Ting CT; Lee WL
    Int J Cardiol; 2006 Mar; 107(3):415-6. PubMed ID: 16503265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF levels in patients with peripheral arterial occlusive disease receiving LDL-apheresis.
    Ferrero S
    J Clin Apher; 2004; 19(3):160; author reply 161. PubMed ID: 15493053
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticardiolipin antibodies are not associated with restenosis or endothelial activation after percutaneous transluminal angioplasty.
    Tsakiris DA; Tschöpl M; Jäger K; Wolf F; Marbet GA
    Int Angiol; 1997 Jun; 16(2):88-93. PubMed ID: 9257668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a) and other serum lipid subfractions influencing primary patency after infrainguinal percutaneous transluminal angioplasty.
    Giovanetti F; Gargiulo M; Laghi L; D'Addato S; Maioli F; Muccini N; Borghi C; Stella A
    J Endovasc Ther; 2009 Jun; 16(3):389-96. PubMed ID: 19642794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smooth muscle cell migration promoting activity of plasma predicts restenosis in patients with peripheral arterial occlusive disease undergoing angioplasty.
    Roller RE; Janisch S; Kvas E; Schnedl WJ; Binder BR; Wojta J; Korninger C
    Thromb Haemost; 2000 Dec; 84(6):1113-6. PubMed ID: 11154122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies.
    Sandri M; Adams V; Gielen S; Linke A; Lenk K; Kränkel N; Lenz D; Erbs S; Scheinert D; Mohr FW; Schuler G; Hambrecht R
    Circulation; 2005 Jun; 111(25):3391-9. PubMed ID: 15956121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
    Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
    Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated levels of soluble E-selectin in diabetic patients with severe symptomatic peripheral arterial occlusive disease requiring angioplasty. A possible role in diabetic vascular disease?
    Elhadd TA; Kennedy G; McLaren M; Stonebridge PA; Shaw WJ; Belch JJ
    Int Angiol; 2000 Jun; 19(2):171-5. PubMed ID: 10905802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of fibrinogen and hematocrit on the early outcome of angioplasty in patients with PAOD.
    Rudofsky G; Strubel G; Michler E; Kuegler C; Biro F
    J Endovasc Ther; 2004 Apr; 11(2):125-31. PubMed ID: 15056033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic and intracardiac vascular endothelial growth factor and angiopoietin-1 and -2 levels in coronary artery disease: effects of angioplasty.
    Jaumdally RJ; Varma C; Blann AD; MacFadyen RJ; Lip GY
    Ann Med; 2007; 39(4):298-305. PubMed ID: 17558601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor in plasma of patients undergoing peripheral angioplasty.
    Roller RE; Renner W; Tischler R; Pilger E; Schnedl WJ
    Thromb Haemost; 2001 Jun; 85(6):1119-20. PubMed ID: 11434696
    [No Abstract]   [Full Text] [Related]  

  • 12. Endovascular treatment of peripheral vascular disease.
    Allaqaband S; Kirvaitis R; Jan F; Bajwa T
    Curr Probl Cardiol; 2009 Sep; 34(9):359-476. PubMed ID: 19664498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Percutaneous transluminal angioplasty in treatment of lower limb peripheral arterial disease in diabetes patients: analysis of 150 cases].
    Zhuang BX; Ma LB; Yu CL; Zhang T; Yang M; Shi B; Shi DZ
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1821-4. PubMed ID: 17922990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of heparin on blood vascular endothelial growth factor levels in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Pyda M; Korybalska K; Ksiazek K; Grajek S; Lanocha M; Lesiak M; Wiśniewska-Elnur J; Olasińska A; Breborowicz A; Cieśliński A; Witowski J
    Am J Cardiol; 2006 Oct; 98(7):902-5. PubMed ID: 16996870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of low-density lipoprotein apheresis in patients with peripheral arterial occlusive disease undergoing hemodialysis treatment.
    Morimoto S; Yano Y; Maki K; Sawada K; Iwasaka T
    Am J Nephrol; 2007; 27(6):643-8. PubMed ID: 17878713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrograde posterior tibial artery access for below-the-knee percutaneous revascularization by means of sheathless approach and double wire technique.
    Fusaro M; Dalla Paola L; Biondi-Zoccai GG
    Minerva Cardioangiol; 2006 Dec; 54(6):773-7. PubMed ID: 17167389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose simultaneous delivery of adenovirus encoding hepatocyte growth factor and vascular endothelial growth factor in dogs enhances liver proliferation without systemic growth factor elevation.
    Atta HM; Al-Hendy A; Salama SA; Shaker OG; Hammam OA
    Liver Int; 2009 Aug; 29(7):1022-30. PubMed ID: 19515220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endovascular treatment of the internal iliac artery in peripheral arterial disease.
    Huétink K; Steijling JJ; Mali WP
    Cardiovasc Intervent Radiol; 2008; 31(2):391-3. PubMed ID: 17610115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation.
    Artini PG; Monti M; Matteucci C; Valentino V; Cristello F; Genazzani AR
    Gynecol Endocrinol; 2006 Aug; 22(8):465-70. PubMed ID: 17012110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of 1-year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study.
    Nylaende M; Kroese AJ; Morken B; Stranden E; Sandbaek G; Lindahl AK; Arnesen H; Seljeflot I
    Vasc Med; 2007 Nov; 12(4):275-83. PubMed ID: 18048463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.